Equol + resveratrol
2 papers study it6 findings
Across all fields, 2 papers: 2 trials in people
- 1 lab in 1 country
- Human trial2
Outcomes
6Tartrate-resistant acid phosphatase 5b
no changein humans1
1 study
Tartrate-resistant acid phosphatase 5b
no changein humans1
Equol + resveratrol has no effect on tartrate-resistant acid phosphatase 5b in humans (p = 0.051).
“Conversely, TRACP-5b levels were unaffected by supplementation (p = 0.051).”
Human trial12 monthsfemalesn = 60
Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial
International journal of molecular sciences
Osteocalcin
upin humans1
1 study
Osteocalcin
upin humans1
Equol + resveratrol improves osteocalcin in humans (p < 0.0001).
“DPD, osteocalcin, and BAP significantly improved in the active group (p < 0.0001 for all) compared to the placebo group.”
Human trial12 monthsfemalesn = 60
Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial
International journal of molecular sciences
Bone mineral density
upin humans1
1 study
Bone mineral density
upin humans1
Equol + resveratrol increases bone mineral density in humans (p = 0.0220).
“the intervention significantly increased BMD measured in the whole body (p = 0.0220) compared with the placebo.”
Human trial12 monthsfemalesn = 60
Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial
International journal of molecular sciences
Sleep quality
upin humans1
1 study
Sleep quality
upin humans1
Equol + resveratrol improves sleep quality in humans (p<0.001).
“Subjects treated with equol and resveratrol also had significant differences in the sleep domain of the NHP (p<0.001).”
Human trialmenopausal women with hot flashes, anxiety and depressive symptomstablet200mg fermented soy containing 10mg of equol and 25mg of resveratrol (1 tablet/day)12 weeksfemalesn = 60
Maturitas
Depressive symptoms
downin humans1
1 study
Depressive symptoms
downin humans1
Equol + resveratrol decreases depressive symptoms in humans (-94.1% (p<0.001)).
“On the HAM-D significant improvements at week 12 were seen in work and activities (-94.1%) (p<0.001).”
Human trialmenopausal women with hot flashes, anxiety and depressive symptomstablet200mg fermented soy containing 10mg of equol and 25mg of resveratrol (1 tablet/day)12 weeksfemalesn = 60
Maturitas
Vaginal dryness
downin humans1
1 study
Vaginal dryness
downin humans1
Equol + resveratrol decreases vaginal dryness in humans (-85.7% (p<0.001)).
“Comparison between placebo and treatment groups revealed statistically significant improvement in particular for dryness of vagina (-85.7%) (p<0.001)”
Human trialmenopausal women with hot flashes, anxiety and depressive symptomstablet200mg fermented soy containing 10mg of equol and 25mg of resveratrol (1 tablet/day)12 weeksfemalesn = 60
Maturitas